["Catecholamine refractory" cardiogenic shock? "Bridging-to-recovery" by implantation of a percutaneous cardiac assist device].
Use of Percutaneous Left Ventricular Assist Device Before Durable Device Implantation in Patients With Cardiac Cachexia: Case Series.
Impella - Current issues and future expectations for the percutaneous, microaxial flow left ventricular assist device.
Saito S, Okubo S, Matsuoka T, Hirota S, Yokoyama S, Kanazawa Y, Takei Y, Tezuka M, Tsuchiya G, Konishi T, Shibasaki I, Ogata K, Fukuda H.
J Cardiol. 2024 Apr;83(4):228-235. doi: 10.1016/j.jjcc.2023.10.008. Epub 2023 Nov 4.
A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction.
Seyfarth M, Sibbing D, Bauer I, Fröhlich G, Bott-Flügel L, Byrne R, Dirschinger J, Kastrati A, Schömig A.
J Am Coll Cardiol. 2008 Nov 4;52(19):1584-8. doi: 10.1016/j.jacc.2008.05.065.
Total percutaneous biventricular assist device implantation for fulminant myocarditis.
Tominaga Y, Toda K, Miyagawa S, Yoshioka D, Kainuma S, Kawamura T, Kawamura A, Nakamoto K, Sakata Y, Sawa Y.
J Artif Organs. 2021 Jun;24(2):254-257. doi: 10.1007/s10047-020-01197-6. Epub 2020 Aug 4.
Use of Percutaneous Left Ventricular Assist Device Before Durable Device Implantation in Patients With Cardiac Cachexia: Case Series.
Salas De Armas IA, Bergeron A, Akkanti B, Akay MH, Scovell A, Patel MK, Patel J, Bhardwaj A, Al Rameni D, Marcano J, Nascimbene A, Kar B, Gregoric ID.
ASAIO J. 2023 Jul 1;69(7):e354-e359. doi: 10.1097/MAT.0000000000001902. Epub 2023 Apr 10.
Left ventricular unloading via percutaneous assist device during extracorporeal membrane oxygenation in acute myocardial infarction and cardiac arrest.
Kieserman JM, Kuznetsov IA, Park J, Schurr JW, Toubat O, Olia S, Bermudez C, Cevasco M, Wald J.
Int J Artif Organs. 2024 Jun;47(6):401-410. doi: 10.1177/03913988241254978. Epub 2024 Jun 10.
Concurrent Left Ventricular Assist Device (LVAD) Implantation and Percutaneous Temporary RVAD Support via CardiacAssist Protek-Duo TandemHeart to Preempt Right Heart Failure.
Schmack B, Weymann A, Popov AF, Patil NP, Sabashnikov A, Kremer J, Farag M, Brcic A, Lichtenstern C, Karck M, Ruhparwar A.
Med Sci Monit Basic Res. 2016 May 5;22:53-7. doi: 10.12659/MSMBR.898897.
Outcomes of Scar-Related Ventricular Tachycardia Ablation With Percutaneous Left Ventricular Assist Device Support.
Kawamura I, Koruth JS, Kusa S, Iwasawa J, Lam J, Ellsworth B, Watanabe K, Nies M, Lampert J, Maan A, Musikantow DR, Turagam MK, Moss N, Whang W, Miller MA, Reddy VY, Dukkipati S.
JACC Clin Electrophysiol. 2025 Dec;11(12):2673-2684. doi: 10.1016/j.jacep.2025.07.016. Epub 2025 Sep 11.
Percutaneous, minimally invasive approach to implantable left ventricular assist device deactivation.
Kidambi S, Shudo Y, Dake MD, Woo YJ, Ha RV.
J Thorac Cardiovasc Surg. 2018 Feb;155(2):653-654. doi: 10.1016/j.jtcvs.2017.08.120. Epub 2017 Sep 13.
Cerebral protection during percutaneous intervention for left ventricular assist device outflow graft obstruction.
Joury A, Patel RAG, Wever-Pinzon J, Eiswirth C, Desai S, Bansal A, Krim SR.
Catheter Cardiovasc Interv. 2022 Aug;100(2):266-273. doi: 10.1002/ccd.30241. Epub 2022 May 25.
Percutaneous interventions.
Tarolli KA.
Crit Care Nurs Q. 2007 Jan-Mar;30(1):12-9. doi: 10.1097/00002727-200701000-00003.
